Clinical Care
Memory & Movement Charlotte Statement on Donanemab
We remain hopeful that this is a true breakthrough in the treatment of Alzheimer’s disease.
Read MoreOur Take on Lecanemab
There are considerable risks — however, we remain hopeful that this is a step forward.
Read More